ARTICLE | Clinical News
Alza regulatory update
February 12, 1996 8:00 AM UTC
AZA's Efidac 24 pseudoephedrine/brompheniramine over-the-counter nasal decongestant/antihistamine received an approvable letter from the FDA. The product uses AZA's OROS osmotic therapeutic system tec...